Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-21-000007 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
44.26% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.99% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.92% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-3.88% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
17.93% · OPTIONAL · VALID
Gross margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
35.18% · CORE · VALID
Operating margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.08% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.13% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.60% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 185.21%
Current 44.26%
Delta -140.96% Capex Intensity Increased
Previous 1.23%
Current 1.99%
Delta 0.76% Cash Generation Increased
Previous 9.80%
Current 10.92%
Delta 1.13% Growth Increased
Previous -7.04%
Current -3.88%
Delta 3.15% Inventory Pressure Decreased
Previous 80.58%
Current 17.93%
Delta -62.64% Margin Decreased
Previous 37.23%
Current 35.18%
Delta -2.05% Profitability Decreased
Previous 14.80%
Current 12.08%
Delta -2.72% R And D Intensity Increased
Previous 3.08%
Current 3.13%
Delta 0.05% Sbc Intensity Decreased
Previous 0.81%
Current 0.60%
Delta -0.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.